Skip to main content
. 2020 Aug 3;2020(8):CD012328. doi: 10.1002/14651858.CD012328.pub2

2.3. Analysis.

2.3

Comparison 2: Subgroup analysis according to baseline risk: Intensification of prophylactic therapy guided by colonoscopic surveillance versus intensification guided by clinical recurrence, Outcome 3: Endoscopic recurrence (Rutgeerts' score ≥i2) at 18 months